CAP-1628987

N/A

Report date: 2025/04/28 10:12:59
NME

Base Information

Drug NameCAP-1628987
Drug Alias NameCAP-1628987
ClassificationSmall molecules
Mechanisms of ActionSREBP cleavage activating protein inhibitors
TargetsSREBP cleavage activating protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCapulus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCapulus Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A